Fexofenadine Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

80 Suppliers, 24 USDMF, 12 CEP/COS, 15 JDMF, 13 EU WC, 9 KDMF, 23 NDC API, 49 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

26 Suppliers

26 Suppliers

DOSSIERs // Finished Dosage Forms

275 Dossiers, 96 FDA Orange Book, 76 Europe, 4 Canada, 5 Australia, 28 South Africa, 66 Listed Dossiers

DRUG PRODUCT COMPOSITION

SUSPENSION;ORAL - 30MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG, TABLET;ORAL - 180MG, TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG, TABLET, ORALLY DISINTEGRATING;ORAL - 30MG, SUSPENSION;ORAL - 30MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers, 37 Kerry, 36 BASF, 29 Roquette, 18 SPI Pharma, 18 Microlex e.U, 15 Gangwal Healthcare, 13 Seppic, 12 Actylis, 12 Sigachi Industries, 12 Gangwal Chemicals, 11 DKSH, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 Corel Pharma Chem, 10 Boai NKY Pharmaceuticals Ltd, 8 Nanjing Well Pharmaceutical, 8 Pluviaendo, 7 DFE Pharma, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Lonza Capsugel, 6 Rochem International Inc, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 5 Prachin Chemical, 5 Pharmatrans-Sanaq, 4 Vasa Pharmachem, 4 ACG Worldwide, 4 Kima Chemical, 4 Novo Excipients, 3 Jai Radhe Sales, 3 The Dow Chemical Company, 3 Alcedo Pharmachem, 3 Ulanqab Kema New Material, 2 Nanjing Bold Chemical, 2 Pharm-RX Chemical, 2 Nomisma Healthcare, 2 Zhejiang Huakang Pharmaceutical, 2 Qualicaps, 2 Seqens, 2 Finar, 2 Pfanstiehl, 2 Vertellus, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Valens Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Aeon Procare, 1 Minakem, 1 Clariant, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Bioplus Life Sciences, 1 Huzhou Sunflower Pharmaceutical

EXCIPIENTS BY APPLICATIONS

113 Fillers, Diluents & Binders, 59 Coating Systems & Additives, 55 Direct Compression, 44 Thickeners and Stabilizers, 44 Disintegrants & Superdisintegrants, 36 Controlled & Modified Release, 36 Granulation, 32 Solubilizers, 31 Taste Masking, 29 Lubricants & Glidants, 28 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 22 Topical, 21 Parenteral, 21 Co-Processed Excipients, 9 Empty Capsules, 9 API Stability Enhancers, 8 Emulsifying Agents, 7 Rheology Modifiers, 5 Coloring Agents, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules

GLOBAL SALES INFORMATION

74 Finished Drug Prices

74 Finished Drug Prices

MARKET PLACE

32 APIs, 2 DOSSIERS // FDF

PATENTS

2 US Patents, 13 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 BioAnalytical Methods, 5 Analytical Solutions, 4 EDQM, 3 USP, 4 JP, 6 Others

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 28 News

Information, Expiry & Status of Health Canada Patents covering Fexofenadine Hydrochloride.

Fexofenadine Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

80 Suppliers

24 USDMF

12 CEP/COS

15 JDMF

13 EU WC

9 KDMF

23 NDC API

49 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

26 Suppliers

DOSSIERs // Finished Dosage Forms

275 Dossiers

96 FDA Orange Book

76 Europe

4 Canada

5 Australia

28 South Africa

66 Listed Dossiers

DRUG PRODUCT COMPOSITION

SUSPENSION;ORAL - 30MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG

TABLET;ORAL - 180MG

TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 60MG

TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG

TABLET, ORALLY DISINTEGRATING;ORAL - 30MG

SUSPENSION;ORAL - 30MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers

37 Kerry

36 BASF

29 Roquette

18 SPI Pharma

18 Microlex e.U

15 Gangwal Healthcare

13 Seppic

12 Actylis

12 Sigachi Industries

12 Gangwal Chemicals

11 DKSH

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 Corel Pharma Chem

10 Boai NKY Pharmaceuticals Ltd

8 Nanjing Well Pharmaceutical

8 Pluviaendo

7 DFE Pharma

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Lonza Capsugel

6 Rochem International Inc

5 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

5 Prachin Chemical

5 Pharmatrans-Sanaq

4 Vasa Pharmachem

4 ACG Worldwide

4 Kima Chemical

4 Novo Excipients

3 Jai Radhe Sales

3 The Dow Chemical Company

3 Alcedo Pharmachem

3 Ulanqab Kema New Material

2 Nanjing Bold Chemical

2 Pharm-RX Chemical

2 Nomisma Healthcare

2 Zhejiang Huakang Pharmaceutical

2 Qualicaps

2 Seqens

TABLET;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons